Conference Coverage
Conference Coverage
Neoadjuvant Checkpoint Inhibition Study Sets New Standard of Care in Melanoma
Results of the first phase 3 oncology study to test checkpoint inhibition without chemotherapy were presented at the annual meeting of the...
Conference Coverage
CARACO: Study Shows Safety of Leaving Uninvolved Lymph Nodes in Ovarian Cancer
Retroperitoneal pelvic and para-aortic lymphadenectomy only adds toxicity without benefit, says an author of research presented at the annual...
Conference Coverage
Abemaciclib Plus Fulvestrant Improves Survival in Advanced Breast Cancer
A switch to a different CDK therapy addressed an unmet need for HR positive, HER2 negative advance breast cancer patients.
Conference Coverage
New Drug Combo Boosts PFS
Patients with Hodgkin lymphoma fared better on a less toxic alternative to gold-standard BrECADD therapy.
Conference Coverage
CML: Asciminib Bests Standard TKIs as Frontline Therapy
For CML, this potent, highly selective TKI significantly improves molecular responses, reduces discontinuations versus standard TKIs.
Conference Coverage
Colorectal Cancer Is Spiking Among Some Young Americans
Up to one third of early-onset colorectal cancer cases are linked to factors that cannot be changed.
Conference Coverage
Mailed Outreach for CRC Screening Appeals Across Races and Ethnicities
More participants chose colonoscopy above FIT — across all racial and ethnic groups — at 12.1% versus 5.6% overall.
Conference Coverage
Carefully Designing De-escalation Trials in Breast Cancer
Doctors highlight several strategies for designing de-escalation trials.
Feature
ADCs for Breast Cancer: Clear Benefits, Manageable Risks
The latest data on several ADCs — their clinical benefit and safety — were the focus of three presentations at the ESMO Breast Cancer Annual...
Latest News
Treating High Stage cSCC: Better Results With Mohs Surgery vs Wide Local Excision, Study Finds
These data support Mohs surgery as being the preferred surgical treatment option for high-stage cSCC, according to the study’s lead author.
Conference Coverage
Late-Night Eaters May Have Increased Risk for Colorectal Cancer
Late eating could disrupt the peripheral circadian rhythm, part of which is found in the GI tract.